Business Development and Growth Strategy Counsel Lead @ (September 2025 - April 2026)
Head of IP Investment Services @ (September 2024 - August 2025)
Chief Business Officer @ (January 2025 - April 2025)
Chief Executive Officer @ IPwe (April 2023 - March 2024)
President @ IPwe (August 2022 - April 2023)
Director, Patent Licensing @ (February 2021 - August 2022)
Head Patent Licensing-US and EMEA @ (December 2019 - February 2021)
Head of Regulatory Compliance @ (September 2017 - December 2019)
Associate @ (July 2016 - September 2017)
Associate @ Frommer Lawrence & Haug LLP (May 2011 - July 2016)
Manager, Regulatory Affairs @ GeneraMedix Inc. (February 2008 - July 2009)
Manager, Technical Affairs Business Development @ (September 2003 - January 2008)
Leann Pinto Education
Seton Hall University School of Law
Doctor of Law (J.D.) (Intellectual Property Law)
2009-2012
The University of Toledo
Bachelor of Science (Pharmaceutical Sciences)
1999-2003
Leann Pinto Skills
Biotechnology
Board of Directors
Business Development
Business Planning
Clinical Trials
Commercialization
FDA
GMP
Intellectual Property
Intellectual Property Law
Legal Research
Legal Writing
Lifesciences
Litigation
Management
Patent Litigation
Patents
Pharmaceutical Industry
Pharmaceutics
Product Development
Regulatory Affairs
Regulatory Submissions
Strategic Partnerships
Strategy
Team Management
Technology Transfer
Trade Secrets
Leann Pinto Summary
Leann Pinto, based in New York, NY, US, is currently a Senior Licensing Executive | Attorney at Patent Platform Services. Leann Pinto brings experience from previous roles at PFTC Group, PKS Compounding Pharmacy, Atta Prime and Providentia. Leann Pinto holds a 2009 - 2012 Doctor of Law (J.D.) in Intellectual Property Law @ Seton Hall University School of Law. With a robust skill set that includes Biotechnology, Board of Directors, Business Development, Business Planning, Clinical Trials and more. Leann Pinto has 1 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Leann Pinto?
Find contact details for 700 million professionals.